Biopharmaceutical Innovation System and the Influence of Policies: The Case of Taiwan (2000-2008)

This article discusses the influence of policies on the development of biopharmaceuticals. We choose the experiences of Taiwan for our empirical study and focus on the evolution between 2000 and 2008; in the period of time the country provides an interesting example for further exploration of biopha...

Full description

Bibliographic Details
Published in:	International Journal of Health Policy and Management
Main Author:	Chao Chen Chung
Format:	Article
Language:	English
Published:	Kerman University of Medical Sciences 2013-01-01
Subjects:	Biotechnology Pharmaceuticals Taiwan Innovation System Policy
Online Access:	http://ijhpm.com/?_action=showPDF&article=2759&_ob=abac3290a5f1fd64467ed2b0231d9f0c&fileName=full_text.pdf.

Similar Items

PHARMACEUTICAL DEVELOPMENT OF FORMULATION BASED ON BIOPHARMACEUTICAL PREPARATIONS FOR GENE THERAPY
by: T. V. Budylskaya, et al.
Published: (2019-01-01)

The Moderating Effects of Dynamic Capability on Radical Innovation and Incremental Innovation Teams in the Global Pharmaceutical Biotechnology Industry
by: Heather Johnson
Published: (2020-04-01)

Increasing Incidence of Nontuberculous Mycobacteria, Taiwan, 2000–2008
by: Eduardo Hernández-Garduño, et al.
Published: (2010-06-01)

The ten innovative events in a century of the development of the Taiwan dental history
by: Feng-Chou Cheng, et al.
Published: (2025-04-01)

Trends in Tuberculosis in Taiwan, 2002–2008
by: Hsiu-Yun Lo, et al.
Published: (2011-08-01)

Evaluating “startup readiness” for researchers: case studies of research-based startups with biopharmaceutical research topics
by: Tomotaka Goji, et al.
Published: (2020-06-01)

Pharmaceutical policy and innovation for rare diseases: A narrative review [version 2; peer review: 1 approved, 2 approved with reservations]
by: Marcela Vieira, et al.
Published: (2023-11-01)

Taiwan Government’s scientific journal supporting policy
by: Hsiu-Ching Hsu, et al.
Published: (2016-08-01)

DOMINANT BUSINESS MODELS IN THE GLOBAL PHARMACEUTICAL INDUSTRY
by: Roman Simonov
Published: (2019-04-01)

Navigating the challenges of community renewable energy: collaborative public sector innovation in Taiwan
by: Natalie W. M. Wong
Published: (2025-04-01)

Strategy and Tactics of Taiwan’s Foreign Policy Against the Background of Aggravated Tensions with China
by: Ya. V. Leksyutina
Published: (2022-12-01)

Public Innovation Policy in the Pharmaceutical Industry: the Cases of the EU and USA
by: Z. A. Mamedyarov
Published: (2017-04-01)

Policy analysis of the English graduation benchmark in Taiwan
by: Chih-Min Shih
Published: (2012-09-01)

Policy analysis of the English graduation benchmark in Taiwan
by: Chih-Min Shih
Published: (2012-09-01)

Development of Science and Technology Parks in Poland: Opportunities for New Modes of Cooperation in the Biopharmaceutical Industry
by: Michal Staszkow, et al.
Published: (2017-03-01)

Taiwan: um futuro formoso para a Ilha? Aspectos de segurança e política
by: Paulo A. Pereira Pinto
Published: (2004-12-01)

Reduction of Influenza and Enterovirus Infection in Taiwan during the COVID-19 Pandemic
by: Chi-Hsin Sally Chen, et al.
Published: (2020-08-01)

Constructing and differentiation of the Politic Area from Policy: Taiwan and the Mechanisms of Management of Pandemic Crisis and Controlling COVID 19
by: Arash Beidollahkhani
Published: (2020-08-01)

General characteristics of top 100 selling drugs: Turkish pharmaceutical market between 2003 and 2016
by: Guven Bektemur, et al.
Published: (2018-09-01)

Análisis de Nivel Sub-Nacional de Política de Desarrollo de Biotecnología en Brasil: Innovación Tecnológica y la Salud Humana en el Estado de Bahía
by: Daniela Caffé de Oliveira, et al.
Published: (2013-04-01)

How the U.S. Can Protect Taiwan in the 21st Century
by: Zachary Surmacz
Published: (2025-06-01)

Surveillance of multidrug-resistant tuberculosis in Taiwan, 2008–2019
by: Mei-Hua Wu, et al.
Published: (2023-02-01)

Preliminary Report on Admission Profiles for Children Under 5 Years Old in Taiwan: Disparities between 2000 and 2009
by: Min-Sho Ku, et al.
Published: (2012-08-01)

THE ROLE OF INNOVATION POLICY IN THE NATIONAL INNOVATION SYSTEM: THE CASE OF ESTONIA; pp. 249–272
by: Janno Reiljan, et al.
Published: (2015-08-01)

U.S. Foreign Policy Towards Taiwan: Obama vs. Trump
by: Nur Seda TEMUR
Published: (2020-07-01)

Editorial: Pharmaceutical Innovation After World War II: From Rational Drug Discovery to Biopharmaceuticals
by: Apostolos Zarros, et al.
Published: (2019-07-01)

“New Go South Policy”: Are Exports and Imports of Taiwan with ASEAN-10 Cointegrated?
by: Chii Torng Liew, et al.
Published: (2019-05-01)

Profiles of pregnant women encountering motor vehicle crashes in Taiwan, 2008–2017
by: Ya-Hui Chang, et al.
Published: (2023-12-01)

Innovation Policy: What, Why, and How
by: Mohammad Ali Sadeghikia
Published: (2018-03-01)

Genetic Diversity and Molecular Epidemiology of Circulating Respiratory Syncytial Virus in Central Taiwan, 2008–2017
by: Chun-Yi Lee, et al.
Published: (2021-12-01)

An investigation of snakebite antivenom usage in Taiwan
by: Chih-Chuan Lin, et al.
Published: (2016-08-01)

Interfaces com a indústria Interfaces with the industry
by: Octavio A. C. Antunes
Published: (2005-12-01)

Mission oriented innovation policy: challenge and opportunitiez
by: Mohammad Ali Sadeghikia
Published: (2021-03-01)

Indigenous Education in Taiwan: Policy Gaps, Community Voices, and Pathways Forward
by: Jia Mao, et al.
Published: (2025-09-01)

Strategic aspects of staffing industrial biopharmaceutical companies
by: A. S. Glazkova, et al.
Published: (2020-01-01)

Heritage Tourism in Taiwan’s Desinicized Nationalism
by: Duarte B. Morais, et al.
Published: (2010-04-01)

Enhancing Taiwan's healthcare sustainability: A Delphi study on national medicines policy reforms
by: Chih-Fen Huang, et al.
Published: (2024-11-01)

Tracing National and Global Forces in a Taiwanese SME's Product Innovation
by: Tommy Tsung Ying Shih
Published: (2013-11-01)

A sustainable balance between innovation and risk: How the “right to science” affects China’s medical biotechnology regulatory policy
by: Yiping Han, et al.
Published: (2024-12-01)

Brucellosis, Taiwan, 2011
by: Yu-Chung Chuang, et al.
Published: (2011-12-01)